Scorpius BioManufacturing

Articles

Best Practices for Tech Transfer to Avoid Manufacturing Pitfalls

Ensure the success of clinical biomanufacturing programs by focusing on key tech transfer practices from the sponsor, commercial, scientific, and program management stakeholders.

Four Critical Aspects of Clinical Development, Manufacturing, and Analysis for Biologics CDMO

Scorpius BioManufacturing discusses the importance of selecting the right CDMO for your next clinical biologic campaign. They cover what attributes are needed through evaluating analytical integration as well as new technologies to look for that will mitigate risk and speed your drug’s manufacturing timelines,